Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Rinse
Brand Name
Stellalife Vega Oral Care Rinse
Generic Name
Rinse
Active Ingredient
Azadirachta Indica BarkCategory
Non-Standardized Fungal Allergenic Extract [EPC]
Variants
2
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Stellalife Vega Oral Care Rinse, you must consult a qualified healthcare professional.
Detailed information about Stellalife Vega Oral Care Rinse
Azadirachta Indica Bark is a non-standardized plant allergenic extract used in clinical immunology for the diagnosis and treatment of specific hypersensitivity reactions. It belongs to the class of allergenic extracts used primarily in skin testing and subcutaneous immunotherapy.
Dosage for Azadirachta Indica Bark is highly individualized and must be determined by an allergist based on the patient's sensitivity level. There is no 'standard' dose for all patients.
Azadirachta Indica Bark is generally considered safe for use in children, provided the child is old enough to cooperate with the procedure and the benefits outweigh the risks.
No specific dose adjustments are required for patients with renal impairment, as the extract is not primarily cleared by the kidneys. However, the patient's overall health and ability to tolerate a systemic reaction must be considered.
No dose adjustments are required for hepatic impairment. The metabolic pathway for allergenic proteins does not involve the liver's CYP450 system.
Caution is advised in elderly patients, particularly those with underlying cardiovascular disease. The dose may need to be adjusted or the treatment avoided if the patient is taking beta-blockers, which can complicate the treatment of an allergic reaction.
Azadirachta Indica Bark extracts are for professional use only and must never be self-administered by the patient.
Consistency is critical in immunotherapy. If a dose is missed during the build-up phase, the next dose may need to be reduced depending on how much time has elapsed.
An overdose of Azadirachta Indica Bark extract can lead to a severe systemic reaction or anaphylaxis.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not attempt to adjust your dose or administration schedule without medical guidance.
The most frequent side effects associated with Azadirachta Indica Bark are localized to the site of administration. These are expected immunological responses and usually do not require discontinuation of therapy.
Azadirachta Indica Bark extract is a potent biological agent. It must only be used by clinicians who are experts in allergy and immunology. Patients must be fully informed of the risks of immunotherapy, particularly the risk of anaphylaxis. Before starting treatment, a thorough medical history must be taken to identify any conditions that might make a systemic reaction more dangerous.
No specific FDA black box warning exists solely for Azadirachta Indica Bark, but it falls under the mandatory class-wide warnings for all allergenic extracts. These warnings emphasize that:
While there are few absolute contraindications, the following combinations are generally avoided due to extreme safety risks:
Azadirachta Indica Bark must NEVER be used in the following circumstances:
Azadirachta Indica Bark is classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and it is not known whether the extract can cause fetal harm.
It is not known whether Azadirachta Indica Bark allergenic proteins are excreted in human milk. However, because these are large proteins and the amount administered is very small, it is highly unlikely that they would be absorbed intact by the nursing infant in any significant quantity. The American Academy of Allergy, Asthma & Immunology (AAAAI) generally considers immunotherapy to be compatible with breastfeeding.
Azadirachta Indica Bark extract acts as an exogenous antigen. At the molecular level, the extract contains various proteins and glycoproteins that function as allergens.
Common questions about Stellalife Vega Oral Care Rinse
Azadirachta Indica Bark extract is primarily used in the field of allergy and immunology for two purposes: diagnosing and treating allergies to the Neem tree. As a diagnostic tool, it is used in skin prick tests to see if a patient has an IgE-mediated allergic sensitivity to the proteins found in the tree's bark and pollen. If a patient is found to be highly allergic and their symptoms are not controlled by other means, the extract is used in immunotherapy, also known as allergy shots. This involves giving the patient gradually increasing doses of the extract to help their immune system build up a tolerance. Over time, this can significantly reduce symptoms like sneezing, itchy eyes, and asthma caused by environmental exposure to Neem.
The most common side effects are localized reactions at the site where the extract was injected or applied. For most patients, this includes redness, itching, and a raised bump similar to a mosquito bite, which usually appears within minutes and fades within a few hours. Some patients may also experience 'delayed' local reactions, where the area becomes swollen and warm several hours later. While these local reactions are common and usually harmless, they should be monitored. Systemic reactions, such as hives or sneezing, are less common but indicate a more widespread immune response. Because of the risk of a severe reaction like anaphylaxis, all patients must be observed for at least 30 minutes after receiving an injection.
There is no known direct chemical interaction between alcohol and Azadirachta Indica Bark extract. However, healthcare providers generally recommend avoiding alcohol for several hours before and after receiving an allergy injection. Alcohol causes blood vessels to dilate (expand), which can potentially speed up the absorption of the allergen into your bloodstream, increasing the risk of a systemic allergic reaction. Furthermore, alcohol can mask the early symptoms of an allergic reaction or make it more difficult for you to recognize that something is wrong. To ensure maximum safety during the 24 hours surrounding your injection, it is best to remain sober and observant of any physical changes.
The safety of Azadirachta Indica Bark during pregnancy is a matter of careful risk management. It is classified as Category C, meaning there is not enough data to rule out risks. Most allergists will not start a new course of immunotherapy (the 'build-up' phase) during pregnancy because the risk of a severe allergic reaction could deprive the fetus of oxygen. However, if a woman is already on a stable 'maintenance' dose and has been tolerating the injections well before becoming pregnant, many doctors will allow her to continue the treatment. The goal is to avoid any reaction that would require the use of epinephrine or cause a drop in blood pressure. Always inform your allergist immediately if you become pregnant.
When used for diagnostic testing, Azadirachta Indica Bark works almost instantly, with results appearing within 15 to 20 minutes. However, when used as a treatment (immunotherapy), the process is much slower. Most patients do not notice a significant decrease in their allergy symptoms until they reach the 'maintenance phase,' which typically takes 3 to 6 months of weekly injections. Full effectiveness and long-term protection usually require a consistent treatment plan lasting 3 to 5 years. It is important to have realistic expectations and understand that allergy shots are a long-term disease-modifying therapy rather than a quick fix for immediate symptom relief.
Yes, you can stop taking Azadirachta Indica Bark injections suddenly without experiencing a 'withdrawal' in the traditional sense, as it is not an addictive substance or a hormone. However, stopping the treatment prematurely, especially before completing the full 3-to-5-year course, usually means that your allergy symptoms will eventually return. The immune tolerance built up during the shots may not be permanent if the maintenance phase is cut short. If you need to stop treatment due to side effects, cost, or scheduling issues, you should discuss it with your allergist. They can help you determine if a different treatment plan or a slower tapering of the shots is appropriate for your situation.
If you miss a dose of Azadirachta Indica Bark immunotherapy, you should contact your allergist's office as soon as possible to reschedule. Do not attempt to 'double up' on your next dose or take an extra dose later. The safety of immunotherapy depends on a very specific schedule of exposure. If you miss only a few days, your doctor may give you your regular dose. However, if you miss several weeks, your immune system's sensitivity may have increased, and your doctor will likely need to reduce your dose for safety before gradually building it back up. Consistency is the most important factor in both the safety and the success of the treatment.
There is no clinical evidence to suggest that Azadirachta Indica Bark allergenic extract causes weight gain. Unlike oral corticosteroids (such as prednisone), which are sometimes used to treat severe allergies and are well-known for causing weight gain and fluid retention, allergenic extracts are biological proteins that work locally on the immune system. They do not affect your metabolism, appetite, or fat distribution. If you experience weight gain while undergoing immunotherapy, it is likely due to other factors, such as other medications you may be taking or changes in your lifestyle. You should discuss any unexpected weight changes with your primary care physician to identify the underlying cause.
Azadirachta Indica Bark can be taken alongside many common medications, but there are some very important exceptions. You must tell your doctor if you are taking beta-blockers (often prescribed for high blood pressure or heart issues) or ACE inhibitors, as these can make allergic reactions much more dangerous and harder to treat. Additionally, you must stop taking antihistamines several days before a skin test, as they will block the reaction and give a false result. Most other routine medications for cholesterol, diabetes, or thyroid issues do not interact with allergy shots. Always provide your allergist with a complete and updated list of every medication and supplement you use.
The concept of 'generic' vs. 'brand name' is slightly different for allergenic extracts like Azadirachta Indica Bark compared to regular pills. These extracts are biological products, and while they are produced by several different specialized laboratories (such as Greer, ALK, or HollisterStier), they are all considered 'non-standardized' extracts. This means that while the extracts from different companies are similar, they are not identical 'generics' in the way that ibuprofen is. Your allergist will usually stick with one manufacturer's extract for your entire course of treatment to ensure consistency in your dosing. Most insurance plans cover these extracts as part of a specialized allergy treatment program.
Other drugs with the same active ingredient (Azadirachta Indica Bark)
These reactions are more systemic in nature but are generally not life-threatening if managed promptly.
> Warning: Stop the administration process and call for emergency medical help immediately if you experience any of these symptoms after an injection.
There are no known long-term 'toxic' effects of Azadirachta Indica Bark, as it is a biological protein extract. However, prolonged immunotherapy can lead to:
While Azadirachta Indica Bark itself may not have a specific individual black box warning, the entire class of Allergenic Extracts carries a general warning regarding the risk of severe systemic reactions.
FDA Class Warning Summary: Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. Patients with unstable asthma are at higher risk. Extracts should only be administered in a setting where emergency equipment and trained personnel are immediately available. Patients should be observed for at least 30 minutes following administration.
Report any unusual symptoms to your healthcare provider immediately. Even a large local reaction should be reported, as it may be a precursor to a systemic reaction at the next dose.
Azadirachta Indica Bark does not typically cause drowsiness. However, if a patient experiences a systemic reaction or receives epinephrine, they should not drive or operate machinery until they have fully recovered and been cleared by a physician.
There is no direct interaction between alcohol and Azadirachta Indica Bark. However, alcohol consumption can cause vasodilation, which may theoretically increase the rate of allergen absorption or worsen the symptoms of an allergic reaction. It is generally advised to avoid alcohol for several hours after an immunotherapy injection.
Immunotherapy is typically a 3-to-5-year commitment. Stopping the treatment early may result in the return of allergy symptoms. There is no 'withdrawal syndrome' associated with stopping Azadirachta Indica Bark, but the immunological tolerance will gradually fade if the maintenance phase is not completed.
> Important: Discuss all your medical conditions with your healthcare provider before starting Azadirachta Indica Bark, especially any history of heart problems or breathing difficulties.
There are no known direct food-drug interactions with Azadirachta Indica Bark. However, patients with a known 'Oral Allergy Syndrome' or cross-reactivity between Neem and certain foods should be monitored. Patients should avoid eating a heavy meal or exercising vigorously immediately before or after an injection, as increased body temperature and circulation can speed up allergen absorption.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter eye drops and cold medicines.
These conditions require a careful risk-benefit analysis by the physician:
Azadirachta Indica belongs to the Meliaceae family (Mahogany family). Patients who are highly allergic to other members of this family or to certain botanical extracts may show cross-reactivity. Healthcare providers should be aware of the patient's full allergy profile to anticipate unusually strong reactions.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Azadirachta Indica Bark. Ensure you provide a full list of all allergies and past reactions.
Azadirachta Indica Bark is used in children, but with caution.
Older adults (over age 65) require special consideration.
There are no specific guidelines for Azadirachta Indica Bark in renal impairment. However, clinicians should be cautious if the patient has end-stage renal disease (ESRD), as their physiological reserve to handle a systemic reaction is diminished.
No adjustments are necessary for patients with liver disease. The processing of allergenic proteins by the immune system does not depend on hepatic function.
> Important: Special populations require individualized medical assessment. Always inform your specialist if you are planning to become pregnant or have new health diagnoses.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Topical) |
| Protein Binding | Primarily to IgE and IgG4 antibodies |
| Half-life | Minutes to hours (Proteins are rapidly degraded) |
| Tmax | 15-30 minutes for local reaction |
| Metabolism | Proteolytic degradation in tissues |
| Excretion | Catabolic amino acid recycling |
Azadirachta Indica Bark is a Non-Standardized Plant Allergenic Extract. It is grouped with other tree bark and pollen extracts used in clinical allergy practice. Unlike 'Standardized' extracts (like those for Grass or Dust Mites), the potency is not measured in units but is defined by the weight of the raw material used per volume of solvent (w/v).